Novo Nordisk
NVO
#25
Rank
A$606.05 B
Marketcap
$143.22
Share price
3.84%
Change (1 day)
-25.27%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): A$28.79 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are A$41.89 Billion. , an increase over its 2023 earnings that were of A$24.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 A$29.85 B22.75%
2023 A$24.32 B57.64%
2022 A$15.42 B5.35%
2021 A$14.64 B12.47%
2020 A$13.02 B13.07%
2019 A$11.51 B-3.35%
2018 A$11.91 B1.79%
2017 A$11.70 B4.52%
2016 A$11.19 B9.42%
2015 A$10.23 B8.24%
2014 A$9.45 B3.45%
2013 A$9.14 B19.02%
2012 A$7.68 B15.21%
2011 A$6.66 B17.71%
2010 A$5.66 B24.78%
2009 A$4.53 B10.62%
2008 A$4.10 B55.97%
2007 A$2.63 B7.07%
2006 A$2.45 B18.18%
2005 A$2.07 B11.33%
2004 A$1.86 B
2002 A$1.15 B-14.39%
2001 A$1.34 B-52.82%
2000 A$2.85 B250%
1999 A$0.81 B31.21%
1998 A$0.62 B34.31%
1997 A$0.46 B11.46%
1996 A$0.41 B9.03%
1995 A$0.38 B-3.15%
1994 A$0.39 B-0.67%
1993 A$0.39 B45.38%
1992 A$0.27 B-13.81%
1991 A$0.31 B37.12%
1990 A$0.23 B-0.79%
1989 A$0.23 B26.2%
1988 A$0.18 B24.97%
1987 A$0.14 B-0.9%
1986 A$0.14 B-7.78%
1985 A$0.16 B24.87%
1984 A$0.12 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$10.94 B-63.34%๐Ÿ‡บ๐Ÿ‡ธ USA
A$19.98 B-33.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$13.21 Billion-144.24%๐Ÿ‡บ๐Ÿ‡ธ USA
A$12.51 B-58.07%๐Ÿ‡ซ๐Ÿ‡ท France